Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v1-EN
Language French English
Date Updated 2019-10-21 2018-07-23
Drug Identification Number 02229702 02229702
Brand name VAQTA VAQTA
Common or Proper name hepatitis A vaccine, purified inactivated Suspension for injection hepatitis A vaccine, purified inactivated Suspension for injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients HEPATITIS A VACCINE, INACTIVATED HEPATITIS A VACCINE, INACTIVATED
Strength(s) 50UNIT 50UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 50U/1ML 1DOSE VIAL 50U/1ML 1DOSE VIAL
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2018-07-30 2018-07-24
Actual start date 2018-07-27
Estimated end date 2019-12-31 2018-12-31
Actual end date 2019-10-18
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination. Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.
Health Canada comments